Preoperative Acetaminophen and Carbohydrate Loading
Impact of Preoperative Acetaminophen and Carbohydrate Loading to on Pain and Functional Status in Patients Undergoing Mohs Micrographic Surgery for Non-melanoma Skin Cancers
1 other identifier
interventional
101
1 country
1
Brief Summary
The study's goal is to assess impact of preoperative acetaminophen and oral carbohydrate drinks on pain and functional status experienced by patients undergoing Mohs micrographic surgery for non-melanoma skin cancers. Patients are randomly assigned to receive standard of care or preoperative acetaminophen 1000 mg and Gatorade sports drinks 2 packets before surgery. Patients are then asked to rate their level of pain, anxiety, thirst, hunger, fatigue on a scale of 0-100 on day of surgery before surgery has started, after clearance of skin cancer, and at the end of the visit. Patients are contacted by phone 48 hours after their surgery to assess their maximum level of post-operative pain (rated from 0-100), usage of over the counter or prescribed pain medications, and presence of complications e.g. bleeding, infection, dehiscence. Differences in perioperative functional status and pain medication usage are compared between patients in control and intervention groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 6, 2017
CompletedFirst Posted
Study publicly available on registry
April 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedResults Posted
Study results publicly available
October 7, 2019
CompletedOctober 7, 2019
October 1, 2019
1.5 years
March 6, 2017
July 12, 2019
October 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum Pain Score
Rated on a pain scale of 0-100. Higher score means worse outcome; lower score means better outcome.
Day of surgery
Secondary Outcomes (6)
Thirst
Day of surgery
Hunger
Day of surgery
Anxiety
Day of surgery
Fatigue
Day of surgery
Number of Participants Using Post-operative Analgesic
48 hours after surgery
- +1 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONThe control group will receive usual perioperative care including patient education on diagnosis, treatment and prognosis of skin cancer, encouragement of food and fluid intake prior to and during the surgery as needed, and acetaminophen per patient request.
Intervention
EXPERIMENTALThe intervention group, in addition to usual care, will receive Acetaminophen 1000mg and commercially available carbohydrate drink (two pouches of Gatorade Prime Sports Fuel drink containing 50gm carbohydrate in approximately 250ml fluid total) at the beginning of the surgery.
Interventions
Eligibility Criteria
You may qualify if:
- Adult patients undergoing Mohs micrographic surgery for non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma)
You may not qualify if:
- history of liver transplant, hepatitis, or cirrhosis, those required to be NPO for subsequent closure by other surgical specialties, or those with known allergy to acetaminophen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tufts Dermatology
Boston, Massachusetts, 02111, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Bichchau Nguyen, Principal Investigato
- Organization
- Tufts Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Bichchau Nguyen, M.D.
Tufts Medical Center/Tufts University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2017
First Posted
April 27, 2017
Study Start
July 1, 2016
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
October 7, 2019
Results First Posted
October 7, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share